These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 31506938)

  • 21. Epithelial to mesenchymal transition markers are associated with an increased metastatic risk in primary cutaneous squamous cell carcinomas but are attenuated in lymph node metastases.
    Toll A; Masferrer E; Hernández-Ruiz ME; Ferrandiz-Pulido C; Yébenes M; Jaka A; Tuneu A; Jucglà A; Gimeno J; Baró T; Casado B; Gandarillas A; Costa I; Mojal S; Peña R; de Herreros AG; García-Patos V; Pujol RM; Hernández-Muñoz I
    J Dermatol Sci; 2013 Nov; 72(2):93-102. PubMed ID: 23928229
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibiting the redox function of APE1 suppresses cervical cancer metastasis via disengagement of ZEB1 from E-cadherin in EMT.
    Li Q; Zhou ZW; Duan W; Qian CY; Wang SN; Deng MS; Zi D; Wang JM; Mao CY; Song G; Wang D; Westover KD; Xu CX
    J Exp Clin Cancer Res; 2021 Jul; 40(1):220. PubMed ID: 34210327
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polypyrimidine tract-binding protein 1-mediated down-regulation of ATG10 facilitates metastasis of colorectal cancer cells.
    Jo YK; Roh SA; Lee H; Park NY; Choi ES; Oh JH; Park SJ; Shin JH; Suh YA; Lee EK; Cho DH; Kim JC
    Cancer Lett; 2017 Jan; 385():21-27. PubMed ID: 27836735
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ATP6L promotes metastasis of colorectal cancer by inducing epithelial-mesenchymal transition.
    Wang J; Chen D; Song W; Liu Z; Ma W; Li X; Zhang C; Wang X; Wang Y; Yang Y; Cao W; Qi L
    Cancer Sci; 2020 Feb; 111(2):477-488. PubMed ID: 31840304
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NRF2 activates a partial epithelial-mesenchymal transition and is maximally present in a hybrid epithelial/mesenchymal phenotype.
    Bocci F; Tripathi SC; Vilchez Mercedes SA; George JT; Casabar JP; Wong PK; Hanash SM; Levine H; Onuchic JN; Jolly MK
    Integr Biol (Camb); 2019 Jun; 11(6):251-263. PubMed ID: 31329868
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The regulatory effects of metformin on the [SNAIL/miR-34]:[ZEB/miR-200] system in the epithelial-mesenchymal transition(EMT) for colorectal cancer(CRC).
    Wang Y; Wu Z; Hu L
    Eur J Pharmacol; 2018 Sep; 834():45-53. PubMed ID: 30017802
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glypican-3 induces a mesenchymal to epithelial transition in human breast cancer cells.
    Castillo LF; Tascón R; Lago Huvelle MR; Novack G; Llorens MC; Dos Santos AF; Shortrede J; Cabanillas AM; Bal de Kier Joffé E; Labriola L; Peters MG
    Oncotarget; 2016 Sep; 7(37):60133-60154. PubMed ID: 27507057
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IGFBP2 promotes salivary adenoid cystic carcinoma metastasis by activating the NF-κB/ZEB1 signaling pathway.
    Yao X; Wang Y; Duan Y; Zhang Q; Li P; Jin R; Tao Y; Zhang W; Wang X; Jing C; Zhou X
    Cancer Lett; 2018 Sep; 432():38-46. PubMed ID: 29885520
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor budding at the invasive front of colorectal cancer may not be associated with the epithelial-mesenchymal transition.
    Yamada N; Sugai T; Eizuka M; Tsuchida K; Sugimoto R; Mue Y; Suzuki M; Osakabe M; Uesugi N; Ishida K; Otsuka K; Matsumoto T
    Hum Pathol; 2017 Feb; 60():151-159. PubMed ID: 27836787
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pterostilbene inhibits triple-negative breast cancer metastasis via inducing microRNA-205 expression and negatively modulates epithelial-to-mesenchymal transition.
    Su CM; Lee WH; Wu AT; Lin YK; Wang LS; Wu CH; Yeh CT
    J Nutr Biochem; 2015 Jun; 26(6):675-85. PubMed ID: 25792283
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SIX1 promotes epithelial-mesenchymal transition in colorectal cancer through ZEB1 activation.
    Ono H; Imoto I; Kozaki K; Tsuda H; Matsui T; Kurasawa Y; Muramatsu T; Sugihara K; Inazawa J
    Oncogene; 2012 Nov; 31(47):4923-34. PubMed ID: 22286765
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phenotypic Heterogeneity and Metastasis of Breast Cancer Cells.
    Hapach LA; Carey SP; Schwager SC; Taufalele PV; Wang W; Mosier JA; Ortiz-Otero N; McArdle TJ; Goldblatt ZE; Lampi MC; Bordeleau F; Marshall JR; Richardson IM; Li J; King MR; Reinhart-King CA
    Cancer Res; 2021 Jul; 81(13):3649-3663. PubMed ID: 33975882
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vascular endothelial growth factor C disrupts the endothelial lymphatic barrier to promote colorectal cancer invasion.
    Tacconi C; Correale C; Gandelli A; Spinelli A; Dejana E; D'Alessio S; Danese S
    Gastroenterology; 2015 Jun; 148(7):1438-51.e8. PubMed ID: 25754161
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinicopathological significance of ZEB1 protein in patients with hepatocellular carcinoma.
    Zhou YM; Cao L; Li B; Zhang RX; Sui CJ; Yin ZF; Yang JM
    Ann Surg Oncol; 2012 May; 19(5):1700-6. PubMed ID: 21584833
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MiR-652 inhibits acidic microenvironment-induced epithelial-mesenchymal transition of pancreatic cancer cells by targeting ZEB1.
    Deng S; Li X; Niu Y; Zhu S; Jin Y; Deng S; Chen J; Liu Y; He C; Yin T; Yang Z; Tao J; Xiong J; Wu H; Wang C; Zhao G
    Oncotarget; 2015 Nov; 6(37):39661-75. PubMed ID: 26498682
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of EMT inducers integrin-linked kinase (ILK) and ZEB1 in phyllodes breast tumors is associated with aggressive phenotype.
    Akrida I; Nikou S; Gyftopoulos K; Argentou M; Kounelis S; Zolota V; Bravou V; Papadaki H
    Histol Histopathol; 2018 Sep; 33(9):937-949. PubMed ID: 29608014
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mesenchymal stromal cells induce epithelial-to-mesenchymal transition in human colorectal cancer cells through the expression of surface-bound TGF-β.
    Mele V; Muraro MG; Calabrese D; Pfaff D; Amatruda N; Amicarella F; Kvinlaug B; Bocelli-Tyndall C; Martin I; Resink TJ; Heberer M; Oertli D; Terracciano L; Spagnoli GC; Iezzi G
    Int J Cancer; 2014 Jun; 134(11):2583-94. PubMed ID: 24214914
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loss of the polycomb protein Mel-18 enhances the epithelial-mesenchymal transition by ZEB1 and ZEB2 expression through the downregulation of miR-205 in breast cancer.
    Lee JY; Park MK; Park JH; Lee HJ; Shin DH; Kang Y; Lee CH; Kong G
    Oncogene; 2014 Mar; 33(10):1325-35. PubMed ID: 23474752
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epigenetic suppression of E-cadherin expression by Snail2 during the metastasis of colorectal cancer.
    Hu Y; Dai M; Zheng Y; Wu J; Yu B; Zhang H; Kong W; Wu H; Yu X
    Clin Epigenetics; 2018 Dec; 10(1):154. PubMed ID: 30541610
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PDLIM1 Stabilizes the E-Cadherin/β-Catenin Complex to Prevent Epithelial-Mesenchymal Transition and Metastatic Potential of Colorectal Cancer Cells.
    Chen HN; Yuan K; Xie N; Wang K; Huang Z; Chen Y; Dou Q; Wu M; Nice EC; Zhou ZG; Huang C
    Cancer Res; 2016 Mar; 76(5):1122-34. PubMed ID: 26701804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.